|
⚲
|
| Keyboard |
| Price Michael Dennis
✚
|
|
|---|---|
| CIK # | 0001247313 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001247313] | |
| 4 | [0001247313] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Price Michael Dennis | |
| Akcea Therapeutics Inc | |
| Novelion Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akcea Therapeutics Inc AKCA
Common Stock
|
2020-10-12 | Tender | 50,000 | $18.15 | 907,500 |
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-10-12 | Disposed to issuer | 300,000 | $3.37 | 1,011,000 |
|
Akcea Therapeutics Inc AKCA
Common Stock
|
2020-05-18 | Grant | 50,000 | $0.00 | |
|
Akcea Therapeutics Inc AKCA
Stock Option (right to buy) · derivative
|
2020-05-18 | Grant | 300,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2019-09-24 | Tax withheld | 3,926 | $0.76 | 2,984 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-11-27 | Tax withheld | 1,963 | $0.92 | 1,806 |